Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic
- PMID: 32856742
- PMCID: PMC7460929
- DOI: 10.1111/trf.16078
Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic
Conflict of interest statement
J.H. is an employee of Haemonetics Corporation. H.G.K. has recently served on a Data Monitoring Committee for Haemonetics. His opinions do not reflect the policy of the National Institutes of Health or the Department of Health and Human Services.
Figures
References
-
- Strengers PF, Klein HG. Plasma is a strategic resource. Transfusion. 2016;56(12):3133–3137. - PubMed
-
- Patrick R. International Transfers of Plasma on the Availability of Immunoglobulin Therapies. The Source. 2019; (Fall), 10–14. https://www.pptaglobal.org/images/source/2019/Fall/An_Analysis_of_the_Im...
-
- https://www.pptaglobal.org/images/Data/Plasma_Collection/Total_Yearly_Co.... Accessed on 09/04/2020.
-
- Hartmann J. Google trends as an early indicator for shortages of intravenous immunoglobulin (IVIG). Transfusion. 2020;60:1656–1657. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical